Back to Rheumatology
Rheumatologyv2000Evidence-Based

Osteoporosis Risk Assessment Instrument (ORAI)

Identifies women at risk for osteoporosis and recommends bone densitometry. Uses age, weight, and current estrogen use to stratify risk in postmenopausal women.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
orai score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Osteoporosis Risk Assessment Instrument (ORAI) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within rheumatology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

ORAI Score = Age points + Weight points + Estrogen use points

Clinical Pearls & Practice Notes

  • Designed for postmenopausal women aged 45 years and older
  • Not intended for patients at high risk for secondary osteoporosis
  • Results are not diagnostic for osteoporosis
  • Does not replace bone densitometry testing
  • Sensitivity 93.3%, specificity 46.4% at cutoff of 9 points
  • Use clinical judgment alongside this tool

Evidence & Literature Citations

  1. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ. 2000 May 2;162(9):1289-94.
  2. El Maghraoui A, Habbassi A, Ghazi M, Achemlal L, Mounach A, Nouijai A, et al. Validation and comparative evaluation of four osteoporosis risk assessment tools in Moroccan menopausal women. Arch Osteoporos. 2006 Dec;1(1-2):35-42. doi: 10.1007/s11657-006-0006-1.
  3. Rubin KH, Abrahamsen B, Friis-Holmberg T, Hjelmborg JV, Bech M, Hermann AP, et al. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study. Bone. 2013 Sep;56(1):16-22. doi: 10.1016/j.bone.2013.05.002.

Score Interpretation Ranges

Low risk0 – 8 pts

Bone densitometry may not be needed

High risk9 – 26 pts

Consider bone densitometry

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.